 -- EXPAREL average daily sales at 103 of the prior year for the month of November 2020 -- PARSIPPANY, N.J., Dec. 09, 2020 GLOBE NEWSWIRE -- Pacira BioSciences, Inc. Nasdaq: PCRX, the leading provider of innovative non-opioid pain management options, today reported preliminary unaudited net product sales of EXPAREL bupivacaine liposome injectable suspension and iovera of 38.1 million and 0.8 million, respectively, for the month of November 2020. 